Erratum A Novel, Highly Sensitive ALK Antibody 1A4 Facilitates Effective Screening for ALK Rearrangements in Lung Adenocarcinomas by Standard Immunohistochemistry (Journal of Thoracic Oncology (2015) 10(4) (713–716)(S1556086415323753)(10.1097/JTO.0000000000000427));A novel, highly sensitive ALK antibody 1A4 facilitates effective screening for ALK rearrangements in lung adenocarcinomas by standard immunohistochemistry

Journal of Thoracic Oncology

Volumn 10, Issue 4, 2015, Pages 713-716

  Gruber, Kim ^a   Kohlhäufl, Martin ^b   Friedel, Godehard ^b   Ott, German ^a   Kalla, Claudia ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b Klinik Schillerhohe   (Germany)

Author keywords

ALK; Antibody 1A4; Immunohistochemistry; Lung adenocarcinoma; Routine diagnostics

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANTIBODY; CANCER ANTIBODY; DNA; PROTEIN TYROSINE KINASE;

ARTICLE; AUTOMATIC SLIDE STAINER; DIAGNOSTIC TEST ACCURACY STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG ADENOCARCINOMA; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG NEOPLASMS; PROCEDURES;

ADENOCARCINOMA; ANTIBODIES, NEOPLASM; DNA, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84938275479     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2016.02.003     Document Type: Erratum

References (15)

1. Rikova K, Guo A, Zeng Q, Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007 131 1190 1203
2. Soda M, Choi YL, Enomoto M, Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 2007 448 561 566
3. Soda M, Takada S, Takeuchi K, A mouse model for EML4-ALK-positive lung cancer. Proc Natl Acad Sci USA 2008 105 19893 19897
4. Kwak EL, Bang YJ, Camidge DR, Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer. N Engl J Med 2010 363 1693 1703
5. Thunnissen E, Bubendorf L, Dietel M, EML4-ALK testing in non-small cell carcinomas of the lung: A review with recommendations. Virchows Arch 2012 461 245 257
6. Gruber K, Horn H, Kalla J, Detection of rearrangements and transcriptional up-regulation of ALK in FFPE lung cancer specimens using a novel, sensitive, quantitative reverse transcription polymerase chain reaction assay. J Thorac Oncol 2014 9 307 315
7. Mino-Kenudson M, Chirieac LR, Law K, A novel, highly sensitive antibody allows for the routine detection of ALK-rearranged lung adenocarcinomas by standard immunohistochemistry. Clin Cancer Res 2010 16 1561 1571
8. Conklin CMJ, Craddock KJ, Have C, Immunohistochemistry is a reliable screening tool for identification of ALK rearrangement in non-small-cell lung carcinoma and is antibody dependent. J Thorac Oncol 2013 8 45 51
9. Selinger CI, Rogers TM, Russell PA, Testing for ALK rearrangement in lung adenocarcinoma: A multicenter comparison of immunohistochemistry and fluorescent in situ hybridization. Mod Pathol 2013 26 1545 1553
10. Le Quesne J, Maurya M, Yancheva SG, A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material. J Thorac Oncol 2014 9 769 774
11. Hutarew G, Hauser-Kronberger C, Strasser F, Llenos IC, Dietze O, Immunohistochemistry as a screening tool for ALK rearrangement in NSCLC: Evaluation of five different ALK antibody clones and ALK FISH. Histopathology 2014 65 398 407
12. McLeer-Florin A, Moro-Sibilot D, Melis A, Dual IHC and FISH testing for ALK gene rearrangement in lung adenocarcinomas in a routine practice: A French study. J Thorac Oncol 2012 7 348 354
13. Paik JH, Choe G, Kim H, Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: Correlation with fluorescence in situ hybridization. J Thorac Oncol 2011 6 466 472
14. Wang YW, Tu PH, Lin KT, Lin SC, Ko JY, Jou YS, Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancer. Neoplasia 2011 13 704 715
15. Sun JM, Choi YL, Won JK, A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK. J Thorac Oncol 2012 7 e36 e38